Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000624791 | SCV000740896 | likely pathogenic | Inborn genetic diseases | 2015-06-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000723295 | SCV001521158 | pathogenic | Glycogen storage disease, type IV | 2020-07-27 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genomic Research Center, |
RCV000723295 | SCV004171069 | pathogenic | Glycogen storage disease, type IV | 2023-11-26 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000723295 | SCV005016587 | likely pathogenic | Glycogen storage disease, type IV | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Biochemical Molecular Genetic Laboratory, |
RCV000723295 | SCV000854685 | pathogenic | Glycogen storage disease, type IV | 2018-05-24 | no assertion criteria provided | clinical testing |